1. Home
  2. BORR vs EYPT Comparison

BORR vs EYPT Comparison

Compare BORR & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Borr Drilling Limited

BORR

Borr Drilling Limited

N/A

Current Price

$4.46

Market Cap

1.4B

Sector

Energy

ML Signal

N/A

EYPT

EyePoint Pharmaceuticals Inc.

N/A

Current Price

$5.08

Market Cap

1.3B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BORR
EYPT
Founded
2016
1987
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Laboratory Analytical Instruments
Sector
Energy
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
BORR
EYPT
Price
$4.46
$5.08
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$6.25
$31.80
AVG Volume (30 Days)
5.7M
5.6M
Earning Date
05-20-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,539,000.00
Revenue This Year
$5.80
N/A
Revenue Next Year
$21.67
$3,115.57
P/E Ratio
$20.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.45
$3.95
52 Week High
$6.66
$19.11

Technical Indicators

Market Signals
Indicator
BORR
EYPT
Relative Strength Index (RSI) 56.99 30.17
Support Level $3.74 $3.95
Resistance Level $4.51 $15.17
Average True Range (ATR) 0.21 0.81
MACD 0.05 -0.75
Stochastic Oscillator 80.52 10.83

Price Performance

Historical Comparison
BORR
EYPT

About BORR Borr Drilling Limited

Borr Drilling Ltd is an offshore shallow-water drilling contractor providing services to the oil and gas industry. Its operations focus on the ownership, contracting, and operation of jack-up rigs in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production (E&P) customers. The company contracts its rigs on a dayrate basis to drill wells for integrated oil companies, state-owned national oil companies, and independent oil and gas companies. It operates in one reportable segment.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: